Ciclosporin to Protect Renal function In Cardiac Surgery (CiPRICS): a study protocol for a double-blind, randomised, placebo-controlled, proof-of-concept study.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27979834)

Published in BMJ Open on December 15, 2016

Authors

Per Ederoth1, Edgars Grins1, Alain Dardashti1, Björn Brondén1, Carsten Metzsch1, André Erdling1, Shahab Nozohoor2, Arash Mokhtari2, Magnus J Hansson3, Eskil Elmér3, Lars Algotsson1, Stefan Jovinge4,5, Henrik Bjursten2

Author Affiliations

1: Department of Anesthesiology and Intensive Care, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
2: Department of Cardiothoracic Surgery, Clinical Sciences, Lund University, Skane University Hospital, Lund, Sweden.
3: Department of Mitochondrial Medicine, Clinical Sciences, Lund University, Lund, Sweden.
4: Fredrik Meijer Heart and Vascular Institute Spectrum Health, MI US Van Andel Institute, Grand Rapids, Michigan, USA.
5: Cardiovascular Institute, Stanford University, Stanford, California, USA.

Associated clinical trials:

Ciclosporin to Protect Renal Function In Cardiac Surgery (CiPRICS) | NCT02397213

Articles cited by this

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med (2012) 14.99

Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature (2005) 11.22

Effect of cyclosporine on reperfusion injury in acute myocardial infarction. N Engl J Med (2008) 9.40

Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature (2005) 8.51

The mitochondrial permeability transition pore and its role in cell death. Biochem J (1999) 7.72

Cyclosporine before PCI in Patients with Acute Myocardial Infarction. N Engl J Med (2015) 5.90

Properties of the permeability transition pore in mitochondria devoid of Cyclophilin D. J Biol Chem (2005) 4.29

Mitochondrial permeability transition pore opening during myocardial reperfusion--a target for cardioprotection. Cardiovasc Res (2004) 3.96

Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care (2013) 3.90

Acute kidney injury is associated with increased long-term mortality after cardiothoracic surgery. Circulation (2009) 3.75

Inhibition by cyclosporin A of a Ca2+-dependent pore in heart mitochondria activated by inorganic phosphate and oxidative stress. Biochem J (1988) 3.41

Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet (1981) 3.38

Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol (2009) 3.33

The mitochondrial permeability transition from in vitro artifact to disease target. FEBS J (2006) 3.26

Opening of the mitochondrial permeability transition pore causes depletion of mitochondrial and cytosolic NAD+ and is a causative event in the death of myocytes in postischemic reperfusion of the heart. J Biol Chem (2000) 2.89

Inhibition of Ca2(+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J (1990) 2.84

Long-term survival after cardiac surgery is predicted by estimated glomerular filtration rate. Ann Thorac Surg (2008) 2.65

Propagation of the apoptotic signal by mitochondrial waves. EMBO J (2001) 2.57

Impact of minimal increases in serum creatinine on outcome in patients after cardiothoracic surgery: do we have to revise current definitions of acute renal failure? Crit Care Med (2008) 2.51

Acute kidney injury: a relevant complication after cardiac surgery. Ann Thorac Surg (2011) 2.24

The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem (2003) 2.07

Clinical accuracy of RIFLE and Acute Kidney Injury Network (AKIN) criteria for acute kidney injury in patients undergoing cardiac surgery. Crit Care (2011) 1.67

Pharmacological preconditioning with low-dose cyclosporine or FK506 reduces subsequent ischemia/reperfusion injury in rat kidney. Transplantation (2001) 1.67

Effects of levosimendan on glomerular filtration rate, renal blood flow, and renal oxygenation after cardiac surgery with cardiopulmonary bypass: a randomized placebo-controlled study. Crit Care Med (2013) 1.64

Urinary TIMP-2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS One (2014) 1.59

Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology (2011) 1.58

Control of apoptosis by IP(3) and ryanodine receptor driven calcium signals. Cell Calcium (2001) 1.55

Perioperative increases in serum creatinine are predictive of increased 90-day mortality after coronary artery bypass graft surgery. Circulation (2006) 1.53

Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial. Crit Care Med (2013) 1.52

Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J Biol Chem (2002) 1.44

Molecular mechanisms of apoptosis in the cardiac myocyte. Curr Opin Pharmacol (2001) 1.40

The predictive value of s-cystatin C for mortality after coronary artery bypass surgery. J Thorac Cardiovasc Surg (2016) 1.38

Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. Am J Physiol Heart Circ Physiol (2005) 1.18

Cyclophilin D gene ablation protects mice from ischemic renal injury. Am J Physiol Renal Physiol (2009) 1.16

C-reactive protein increase in unstable coronary disease cause or effect? J Am Coll Cardiol (2005) 1.13

Calcineurin inhibitor nephrotoxicity: a review and perspective of the evidence. Am J Nephrol (2013) 1.02

Vascular mechanisms of cyclosporin-induced hypertension in the rat. J Clin Invest (1994) 1.01

A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation (1983) 1.00

Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport (2003) 0.97

Cyclosporine protects the heart during aortic valve surgery. Anesthesiology (2014) 0.97

Incidence, dynamics, and prognostic value of acute kidney injury for death after cardiac surgery. J Thorac Cardiovasc Surg (2013) 0.95

Interaction of cyclosporine A and the renin-angiotensin system; new perspectives. Curr Drug Metab (2002) 0.90

Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study. Acta Neurochir (Wien) (2008) 0.90

Mitochondrial ca(2+) signaling and cardiac apoptosis. Biol Signals Recept (2001) 0.89

Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest. J Thorac Cardiovasc Surg (2008) 0.89

Cyclosporine protects against ischemia/reperfusion injury in rat kidneys. Toxicology (2005) 0.87

The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial. Heart (2014) 0.86

Cyclosporine A suppresses cyclooxygenase-2 expression in the rat kidney. J Am Soc Nephrol (2002) 0.86

Cyclosporine action on kidneys of rats submitted to normothermic ischaemia and reperfusion. Acta Cir Bras (2008) 0.85

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation. Kidney Int (1995) 0.83

Cyclophilin D-sensitive mitochondrial permeability transition in adult human brain and liver mitochondria. J Neurotrauma (2011) 0.82

Donor preconditioning with a calcineurin inhibitor improves outcome in rat syngeneic kidney transplantation. Transplantation (2009) 0.82

Cyclosporine A protects against apoptosis in ischaemic/reperfused rat kidneys. Clin Exp Pharmacol Physiol (2002) 0.81

Cystatin C as a predictive marker of renal dysfunction and mid-term outcomes following off-pump coronary artery bypass grafting. Heart (2015) 0.80

Erythropoietin and protection of renal function in cardiac surgery (the EPRICS Trial). Anesthesiology (2014) 0.80

N-acetylcysteine for the prevention of acute kidney injury after cardiac surgery. J Clin Pharmacol (2011) 0.79

Functional and pharmacological characteristics of permeability transition in isolated human heart mitochondria. PLoS One (2013) 0.79

Protection of myocardium by cyclosporin A and insulin: in vitro simulated ischemia study in human myocardium. Ann Thorac Surg (2003) 0.78

Knockdown of Cyclophilin D Gene by RNAi Protects Rat from Ischemia/ Reperfusion-Induced Renal Injury. Kidney Blood Press Res (2010) 0.78

Cyclosporine treatment improves mesenteric perfusion and attenuates necrotizing enterocolitis (NEC)-like intestinal injury in asphyxiated newborn piglets during reoxygenation. Intensive Care Med (2011) 0.78

Leg wound infections following cardiac surgery: a scoring system for assessment and management. J Wound Care (2005) 0.77